These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6385635)

  • 1. The effect of acebutolol on plasma lipids, blood glucose and serum insulin levels.
    Lehtonen A
    Acta Med Scand; 1984; 216(1):57-60. PubMed ID: 6385635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of trimazosin and pindolol on serum lipids, blood glucose and serum insulin levels.
    Lehtonen A
    Acta Med Scand; 1985; 218(2):213-6. PubMed ID: 3904336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels.
    Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levels of free fatty acids in plasma, K coefficient and insulin secretion stimulated by intravenous glucose load in patients with hyperthyroidism taking propranolol or acebutolol].
    Gasińska T; Nowak S; Beldzik A; Wawrzyniak L
    Pol Arch Med Wewn; 1994 May; 91(5):324-31. PubMed ID: 8084808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised two way crossover comparison of the effects of six weeks propranolol and acebutolol therapy on plasma lipid profiles in patients with hypertension or ischaemic heart disease.
    Tyagi S; Bhargava M; Bhattacharya J; Khalilullah M
    Indian Heart J; 1990; 42(2):117-9. PubMed ID: 2081608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
    Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
    JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of sotalol on plasma lipids.
    Lehtonen A; Viikari J
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():405s-407s. PubMed ID: 232028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acebutolol on plasma apoproteins and HDL cholesterol subfractions.
    Lehtonen A; Marniemi J; Niittymäki K
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):427-35. PubMed ID: 3922021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre study of the efficacy and tolerance of acebutolol versus atenolol in the long term treatment of mild arterial hypertension.
    De Backer G
    Drugs; 1988; 36 Suppl 2():51-6. PubMed ID: 3063506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension.
    Fuh MM; Shieh SM; Wu DA; Chen YD; Reaven GM
    Arch Intern Med; 1987 Jun; 147(6):1035-8. PubMed ID: 3296980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of medium-term treatment of acebutolol on lipid profile].
    Bossini A; Di Veroli C
    Riv Eur Sci Med Farmacol; 1990 Apr; 12(2):91-8. PubMed ID: 2080313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
    Lehtonen A
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):549-51. PubMed ID: 3154682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
    Oksa A; Gajdos M; Fedelesová V; Spustová V; Dzúrik R
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):79-86. PubMed ID: 7511740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
    Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
    Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of antihypertensive therapy with acebutolol on plasma lipids].
    Román O; Gac JG; Basso B; Pino ME; Pereda T; Valenzuela MA
    Rev Med Chil; 1987 Sep; 115(9):836-41. PubMed ID: 3506276
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin sensitivity after a reduced-fat diet and a monoene-enriched diet in subjects with elevated serum cholesterol and triglyceride concentrations.
    Louheranta AM; Schwab US; Sarkkinen ES; Voutilainen ET; Ebeling TM; Erkkilä AT; Turpeinen AK; Uusitupa MI
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):177-87. PubMed ID: 11079255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose tolerance, plasma lipids and serum insulin in patients with ischaemic heart diseases.
    Christiansen I; Deckert T; Kjerulf K; Midtgaard K; Worning H
    Acta Med Scand; 1968 Oct; 184(4):283-7. PubMed ID: 5710034
    [No Abstract]   [Full Text] [Related]  

  • 18. [Levels of free fatty acids in plasma, tissue utilization coefficient of glucose K and insulin secretion following intravenous glucose load in hyperthyroid patients treated with propranolol or acebutolol].
    Gasińska T; Nowak S; Beldzik A; Wawrzyniak L
    Pol Tyg Lek; 1994 Jan 3-17; 49(1-3):7-10. PubMed ID: 8008680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose tolerance, serum insulin and lipid abnormalities in patients with coronary heart disease.
    Inoue S; Ota M; Iizuka T; Murao S
    Jpn Heart J; 1975 Nov; 16(6):670-82. PubMed ID: 1185889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucose tolerance, insulin and lipids after one week's administration of fenfluramine to overweight patients (author's transl)].
    Weisweiler P; Schwandt P
    MMW Munch Med Wochenschr; 1975 Nov; 117(48):1925-8. PubMed ID: 813120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.